BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of marker genes is 20
| DRUG | PUBCHEM_ID | CANCER_TYPE | BIOMARKER | HGNC_ID | NCT | PUBMED_ID |
|---|---|---|---|---|---|---|
| MK-0752 | 9803433 | Breast Cancer | CD44 | 1681 | NCT00645333 | 23340294 |
| MK-0752 | 9803433 | Breast Cancer | CD24 | 1645 | NCT00645333 | 23340294 |
| MK-0752 | 9803433 | Breast Cancer | ALDH1A1 | 402 | NCT00645333 | 23340294 |
| Demcizumab | 381126731 | Non Small Cell Lung Cancer | DLL4 | 2910 | NCT01189968 | 29188408 |
| Bevacizumab | 103771315 | Breast Cancer | ALDH1A1 | 402 | NCT01190345 | NA |
| Catumaxomab | 135311383 | Pancreatic Cancer | EPCAM | 11529 | NCT00836654 | 22734013 |
| Cyclosporin A | 5284373 | Breast Cancer | ABCG2 | 74 | NCT00983424 | NA |
| Atezolizumab | 377483935 | Non Small Cell Lung Cancer | CD274 | 17635 | NCT02008227 | 34226144 |
| Salazosulfapyridine | 5339 | Non Small Cell Lung Cancer | CD44 | 1681 | UMIN000017854 | 28667792 |
| Bivatuzumab mertansine | 381125874 | Breast Cancer | CD44 | 1681 | NCT02254005 | NA |
| Plerixafor | 65015 | Colon Cancer | CXCR4 | 2561 | NCT02179970 | NA |
| Plerixafor | 65015 | Pancreatic Cancer | CXCR4 | 2561 | NCT02907099 | NA |
| Reparixin | 9838712 | Triple Negative Breast Cancer | CD44 | 1681 | NCT01861054 | 34476645 |
| Reparixin | 9838712 | Triple Negative Breast Cancer | CD24 | 1645 | NCT01861054 | 34476645 |
| Reparixin | 9838712 | Triple Negative Breast Cancer | ALDH1A1 | 402 | NCT01861054 | 34476645 |
| Reparixin | 9838712 | Breast Cancer | CXCR1 | 6026 | NCT01861054 | 31924241 |
| Reparixin | 9838712 | Breast Cancer | CD44 | 1681 | NCT01861054 | 31924241 |
| Reparixin | 9838712 | Breast Cancer | CD24 | 1645 | NCT01861054 | 31924241 |
| Reparixin | 9838712 | Breast Cancer | ALDH1A1 | 402 | NCT01861054 | 31924241 |
| BYL719 | 56649450 | Gastric Cancer | PIK3CA | 8975 | NCT01613950 | NA |